Found: 12
Select item for more details and to access through your institution.
Corrigendum.
- Published in:
- 2022
- Publication type:
- Correction Notice
Acknowledgment.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 1072, doi. 10.1111/hepr.13850
- Publication type:
- Article
Corrigendum.
- Published in:
- 2022
- Publication type:
- Correction Notice
Mitochondrial fission in hepatocytes as a potential therapeutic target for nonalcoholic steatohepatitis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 1020, doi. 10.1111/hepr.13832
- By:
- Publication type:
- Article
Diagnosis of hepatic steatosis based on ultrasound attenuation imaging is not influenced by liver fibrosis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 1009, doi. 10.1111/hepr.13831
- By:
- Publication type:
- Article
Effect of metabolic dysfunction‐associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 975, doi. 10.1111/hepr.13830
- By:
- Publication type:
- Article
Circulating extracellular vesicle‐encapsulated microRNA‐557 induces a proinflammatory immune response and serves as a diagnostic or relapse marker in autoimmune hepatitis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 1034, doi. 10.1111/hepr.13829
- By:
- Publication type:
- Article
Carbon‐ion radiotherapy versus radiofrequency ablation as initial treatment for early‐stage hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 1060, doi. 10.1111/hepr.13827
- By:
- Publication type:
- Article
Serum levels of immunoglobulin M‐free inhibitors of macrophage/CD5L as a predictive and early diagnostic marker for nonalcoholic steatohepatitis‐associated hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 998, doi. 10.1111/hepr.13826
- By:
- Publication type:
- Article
Synthesized HMGB1 peptide prevents the progression of inflammation, steatosis, fibrosis, and tumor occurrence in a non‐alcoholic steatohepatitis mouse model.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 985, doi. 10.1111/hepr.13825
- By:
- Publication type:
- Article
Validation of the easy‐to‐use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 1050, doi. 10.1111/hepr.13824
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 973, doi. 10.1111/hepr.13663
- Publication type:
- Article